Melexis N.V.

Earnings Release • Oct 29, 2025

Press release - Regulated Information

Melexis Q3 2025 results – Third quarter sales of 215.3 million EUR

Intermediate declaration by the Board of Directors

Ieper, Belgium – October 29th, 2025, 07.00 hrs CET

CONFORM IFRS	Q3 2025	Q3 2024	YOY change	Q2 2025	SEQ change
in k EUR			(%)		(%)
Sales	215,287	247,858	-13%	211,589	2%
Gross result	83,425	108,241	-23%	82,602	1%
Gross Margin	38.8%	43.7%		39.0%
EBIT	37,845	64,210	-41%	35,650	6%
EBIT in %	17.6%	25.9%		16.8%
EBITDA	51,397	75,986	-32%	50,086	3%
EBITDA in %	23.9%	30.7%		23.7%
Net result	27,528	51,152	-46%	37,805	-27%
Net result per share (EPS)	0.68	1.27		0.94
CAPEX	5,319	13,901		10,714

Sales for the third quarter of 2025 were 215.3 million EUR, a decrease of 13% compared to the same quarter of the previous year and an increase of 2% compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 2% on sales compared to the same quarter of last year and a negative impact of 1% on sales compared to the previous quarter.

The gross result was 83.4 million EUR or 38.8% of sales, a decrease of 23% compared to the same quarter of last year and an increase of 1% compared to the previous quarter.

R&D expenses were 12.8% of sales, G&A was at 6.1% of sales and Selling was at 2.3% of sales.

The operating result was 37.8 million EUR or 17.6% of sales, a decrease of 41% compared to the same quarter of last year and an increase of 6% compared to the previous quarter.

The net result was 27.5 million EUR or 0.68 EUR per share, a decrease of 46% compared to 51.2 million EUR or 1.27 EUR per share in the third quarter of 2024 and a decrease of 27% compared to the previous quarter.

CONFORM IFRS	9M 2025	9M 2024	YOY change
in k EUR			(%)
Sales	625,124	735,401	-15%
Gross result	241,707	323,791	-25%
Gross Margin	38.7%	44.0%
EBIT	102,479	192,298	-47%
EBIT in %	16.4%	26.1%
EBITDA	142,740	227,657	-37%
EBITDA in %	22.8%	31.0%
Net result	89,931	153,167	-41%
Net result per share (EPS)	2.23	3.79
CAPEX	21,673	46,223

Sales for the first nine months of 2025 were 625.1 million EUR, a decrease of 15% compared to the first nine months of 2024. The EUR/USD exchange rate evolution had a negative impact of 1% on sales compared to the first nine months of 2024.

The gross result was 241.7 million EUR or 38.7% of sales, a decrease of 25% compared to the same period last year. R&D expenses were 13.6% of sales, G&A was at 6.4% of sales and Selling was at 2.3% of sales.

The operating result was 102.5 million EUR or 16.4% of sales, a decrease of 47% compared to 192.3 million EUR in the same nine months of 2024.

The net result was 89.9 million EUR or 2.23 EUR per share, a decrease of 41% compared to 153.2 million EUR or 3.79 EUR per share in the first nine months of 2024.

Outlook

Melexis expects sales in the fourth quarter of 2025 to be in the range of 215 to 220 million EUR. For the full year 2025, Melexis expects sales to be in the range of 840 to 845 million EUR, with a gross profit margin around 39% and an operating margin around 16%, all taking into account a EUR/USD exchange rate of 1.17 for the remainder of the year. For the full year 2025, Melexis expects CAPEX to be around 35 million EUR (previously around 40 million EUR).

Business update

Sales of 215.3 million EUR in the third quarter of 2025 landed just above the top end of the guidance, and resulted in sales of 625.1 million EUR for the first nine months of 2025. The outperforming product lines in the third quarter were motor drivers and pressure sensors.

Sales for non automotive applications represented 12% of total sales in the third quarter of 2025, while 88% of Melexis sales were for automotive applications.

Melexis launched 3 new products in Q3 2025 making a total of 9 new products in the first nine months of 2025. We added a new latch for smaller yet robust motor applications such as automotive seats and windows, and an upgrade to our smart current, voltage & temperature (IVT) sensor enabling more precise temperature measurement in safety-critical applications including automotive batteries and DC fast charging. For smart industrial and consumer sectors we launched an embedded motor driver for applications such as smart fans for server cooling and smart valves.

Quote from CEO Marc Biron

"We delivered a third consecutive quarter of sequential improvement in our operating results. Q3 2025 sales grew thanks to good performances in the five automotive strategic growth areas targeted by Melexis and further growth outside of automotive applications. Gross margin remained stable as anticipated and the EBIT margin rose due to ongoing fixed cost control.

We continued extending our product portfolio, with the number of new products designed for applications outside of automotive such as robotics this year confirming our aim to capture substantial growth in these markets.

Converting our innovations into design wins drives future sales. In Q3 2025 we recorded our two largest design wins year to date, including a motor driver specifically designed for 48V architecture of EV automobiles which is increasingly in demand by our customers.

Overall we are making good progress on our commercial, operational, and strategic objectives, and look forward to sharing more details at our Capital Markets Day on November 5th."

Financial Calendar

• Capital Markets Day: November 5, 2025
• Publication FY 2025 Results: February 4, 2026 (at 7 hrs CET)
• Publication Q1 2026 Results: April 29, 2026 (at 7 hrs CET)
• Publication Q2 2026 Results: July 29, 2026 (at 7 hrs CET)
• Publication Q3 2026 Results: October 28, 2026 (at 7 hrs CET)
• Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET)

The company's results will be discussed in a conference call and an audio webcast on Wednesday, October 29th, 2025 at 10:30 hrs CET.

To register for the conference call (possibility to ask questions)

The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call.

To register for the audio webcast (no possibility to ask questions)

You can register for the audio webcast by clicking here.

For more information:

Investors

Investor Relations

Email: investor@melexis.com

Journalists

Brand & Communications

Email: brandcomms@melexis.com

About Melexis

Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable.

Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health.

Founded in 1989 in Belgium, Melexis has grown to employ over 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide.

For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube.

Disclaimer

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forwardlooking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

Condensed consolidated interim income statement

CONFORM IFRS	Quarter ended	Quarter ended	Nine months ended	Nine months ended	Year ended
	30/9/2025	30/9/2024	30/9/2025	30/9/2024	31/12/2024
in k EUR					audited
Sales	215,287	247,858	625,124	735,401	932,808
Cost of sales	-131,862	-139,617	-383,417	-411,611	-531,457
Gross result	83,425	108,241	241,707	323,791	401,351
R&D	-27,548	-26,565	-84,784	-80,025	-110,252
G&A	-13,126	-12,693	-39,899	-37,210	-51,367
Selling	-4,905	-4,773	-14,544	-14,258	-19,842
Operating result (EBIT)	37,845	64,210	102,479	192,298	219,889
Financial result	-3,013	-1,740	4,900	-6,470	-14,568
Result before taxes	34,832	62,471	107,379	185,827	205,321
Income taxes	-7,304	-11,319	-17,448	-32,660	-33,875
Net result	27,528	51,152	89,931	153,167	171,446
Net result per share in EUR	0.68	1.27	2.23	3.79	4.24

Condensed consolidated interim statement of financial position

CONFORM IFRS in k EUR	Nine months ended 30/9/2025	Nine months ended 30/9/2024	Year ended 31/12/2024 audited
Current Assets :
Cash and cash equivalents	33,321	34,463	32,681
Current investments	404	231	—
A/R Trade	106,768	129,788	102,246
Assets for current tax	29,201	14,683	18,889
Other current assets	106,775	42,903	55,961
Inventories	299,095	252,405	262,815
Total current assets	575,564	474,472	472,593
Non-current assets :
Property, plant and equipment	199,429	208,836	211,120
Leased assets	7,875	7,185	8,801
Intangible fixed assets	1,329	1,297	1,175
Other non-current assets	102,266	172,444	163,581
Deferred tax assets	35,109	32,825	36,985
Total non-current assets	346,008	422,587	421,662
Total assets	921,571	897,059	894,255

CONFORM IFRS	Nine months ended	Nine months ended	Year ended
	30/9/2025	30/9/2024	31/12/2024
in k EUR			audited
Current liabilities :
Derivative financial instruments	—	—	228
Current portion of LT debt	12,166		5,797
Lease liabilities	936	514	2,143
A/P trade	54,490	54,939	63,203
Accrued taxes	5,905	6,326	3,220
Short-term employee benefits accruals	24,486	17,960	18,222
Other current liabilities	5,955	8,521	9,320
Deferred income	4,066	4,412	2,076
Total current liabilities	108,004	92,672	104,210
Non current liabilities :
LT debt less current portion	265,779	187,609	207,525
Lease liabilities	7,073	6,779	6,714
Deferred tax liabilities	2,344	586	3,737
Other non-current liabilities	3,675	4,466	4,567
Total non current liabilities	278,871	199,439	222,544
Shareholders' equity :
Shareholders' capital	565	565	565
Treasury shares	-28,754	—	-4,410
Legal reserve	57	57	57
Retained earnings	478,630	455,810	403,160
Current period's profit	89,931	153,167	171,446
Cumulative translation adjustment	-5,732	-4,650	-3,316
Equity attributable to company owners	534,696	604,948	567,501
Non controlling interests	—	—	—
Total shareholders equity	534,696	604,948	567,501
Total liabilities, shareholders' equity and minority interests	921,571	897,059	894,255

Condensed consolidated interim statement of cash flows

in k EUR Cash flow from operating activities
					audited
	27,528	51,152	89,931	153,167	171,446
Net income Adjustments for :
Operating activities	24,009	26,137	63,092	75,095	90,640
Depreciation and amortisation	12,980	11,275	38,557	33,813	45,639
Depreciation leased assets	572	501	1,704	1,546	2,102
Other provisions	200	-14	-892	126	54
Deferred income	994	-6	1,990	1,486	-849
Financial result	1,958	3,062	4,285	5,464	9,819
Income tax expense/income	7,304	11,319	17,448	32,660	33,875
Operating profit before working capital changes	51,537	77,289	153,023	228,262	262,086
A/R, Trade	-1,940	-10,290	-4,982	-9,582	17,961
Other current assets	-7,265	-18,133	-50,814	-10,474	-23,532
Other non current assets	19,103	20,419	61,315	8,790	17,652
Inventories	-13,857	3,045	-41,945	-3,173	-15,335
A/P	-4,584	-7,345	-8,712	-25,091	-16,828
Employee benefit liabilities	3,769	2,712	6,247	-5,750	-5,471
Other current liabilities	1,387	-528	-3,365	-4,443	-3,644
Cash generated from operations	48,150	67,169	110,767	178,539	232,890
Interest paid	-2,146	-3,044	-7,008	-8,064	-10,750
Income tax paid	-1,504	-11,922	-24,473	-39,365	-48,913
Cash flow from operating activities	44,500	52,204	79,286	131,110	173,227
Cash flow from investing activities
Purchase of PPE and intangible assets (netted)	-7,454	-13,743	-20,896	-40,870	-53,107
Interest received	3	82	118	270	357
Cash provided from investing activities	-7,451	-13,660	-20,777	-40,600	-52,750
Cash flows from financing activities
Proceeds/Repayment of long-and short-term debt	-36,036	-42,209	64,622	2,950	28,663
Repayment leasings	-544	-497	-1,626	-1,458	-2,065
Dividend payment	—	—	-95,976	-96,960	-149,480
Acquisition own shares	-1,033		-24,344		-4,410
Cash provided from financing activities	-37,614	-42,707	-57,323	-95,468	-127,293
Effect of exchange rate changes on cash and cash equivalents	-26	75	-545	71	148
Increase/decrease in cash and cash equivalents	-590	-4,088	640	-4,886	-6,668
Cash at beginning of the period Cash at the end of the period	33,912 33,321	38,551 34,463	32,681 33,321	39,349 34,463	39,349 32,681

Sales per Geography

	Q3 2025	Q3 2024	9M 2025	9M 2024	FY 2024
APAC	61%	61%	62%	60%	60%
Asia Pacific
EMEA	31%	30%	29%	31%	31%
Europe - Middle-East - Africa
NALA	8%	9%	8%	9%	9%
North America - Latin America
TOTAL	100%	100%	100%	100%	100%